RecruitingNot Applicable

Pulmonary Hypertension Biorepository and Registry

United States300 participantsStarted 2020-08-10

Plain-language summary

Establish a pulmonary hypertension registry and biorepository to lead towards a further understanding of the disease.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP)
. The participant has a diagnosis of pulmonary hypertension confirmed by right heart catheterization
. Patient is ≥ 18 years of age or older

Exclusion criteria

. Participant declines to participate (living patients only)
. Participant is unable to provide informed consent (living patients only)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Collect Clinical Data

Timeframe: From Enrollment to 6 Months

Establish a Biorepository

Timeframe: From Enrollment to 6 Months

Biospecimens Collection

Timeframe: From Enrollment to 12 Months

Collaborate

Timeframe: From Enrollment to 24 Months

Trial details

NCT IDNCT04808596

SponsorUniversity of Kansas Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12-31

Contact for this trial

Luigi R Boccardi, Ed.D., MPH

9135884022 lboccardi@kumc.edu

View on ClinicalTrials.gov More Pulmonary Hypertension trials